ADVANCED VAGINAL ADENOCARCINOMA
Clinical trials for ADVANCED VAGINAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED VAGINAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED VAGINAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new weapon against advanced gynecologic cancers
Disease control OngoingThis large, late-stage trial is testing whether adding an experimental drug called triapine to the standard treatment of radiation and chemotherapy improves survival for women with advanced cervical or vaginal cancer. The study will enroll 450 women to compare the new three-part …
Matched conditions: ADVANCED VAGINAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
First human test of oral cancer drug seeks to boost radiation power
Disease control OngoingThis early-stage study is testing a new oral drug called Triapine, given alongside standard chemotherapy (cisplatin) and radiation for advanced cervical or vaginal cancer. The main goals are to find the safest and most effective dose of Triapine and to see how well the body absor…
Matched conditions: ADVANCED VAGINAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC